ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,175Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 3734

$1.46M Total Retail Price of All Prescriptions

Rank: 20 out of 3734

393 Patients Receiving at Least One Drug in Part D
55%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

29% of this provider’s 393 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

30% of this provider’s 393 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 14,147 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

62 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LEVOTHYROXINE SODIUM 850 542 1 2
FUROSEMIDE 756 488 2 7
HYDROCODONE-ACETAMINOPHEN 726 304 S3 3 12
OMEPRAZOLE 617 303 4 4
POTASSIUM CHLORIDE 595 389 5 19
SIMVASTATIN 558 298 6 1
LISINOPRIL 524 266 7 3
OXYCODONE-ACETAMINOPHEN 479 292 S2 8 51
WARFARIN SODIUM 473 374 9 10
METOPROLOL TARTRATE 419 229 10 6
GABAPENTIN 394 231 11 17
CITALOPRAM HBR 309 224 12 16
METOPROLOL SUCCINATE 303 221 13 14
NAMENDA 300 260 14 44
CRESTOR 291 136 15 28
PANTOPRAZOLE SODIUM 286 188 16 22
TRICOR 283 94 17 93
METFORMIN HCL ER 283 172 17 66
CLOPIDOGREL 278 183 19 23
METFORMIN HCL 274 115 20 8
FENOFIBRATE 257 117 21 81
TRAZODONE HCL 256 89 22 49
MIRTAZAPINE 247 143 23 45
ATENOLOL 245 160 24 13
DONEPEZIL HCL 244 172 25 25
CARVEDILOL 219 145 26 30
SPIRIVA 212 109 27 40
AMLODIPINE BESYLATE 209 105 28 5
DIGOXIN 208 174 29 43
PLAVIX 206 148 30 39
ATORVASTATIN CALCIUM 201 127 31 11
SERTRALINE HCL 181 132 32 18
NEXIUM 180 104 33 36
HYDROCHLOROTHIAZIDE 176 105 34 9
LEVOFLOXACIN 171 113 35 116
TIZANIDINE HCL 162 79 36 245
CYMBALTA 157 64 37 67
LYRICA 155 83 38 124
ZOLPIDEM TARTRATE 151 71 39 24
ISOSORBIDE MONONITRATE ER 145 81 40 34
GLIMEPIRIDE 144 107 41 37
BUPROPION HCL SR 143 47 42 165
ZETIA 143 77 42 55
RANITIDINE HCL 140 49 44 32
LOSARTAN POTASSIUM 134 110 45 21
IPRATROPIUM-ALBUTEROL 129 125 46 98
ESCITALOPRAM OXALATE 127 88 47 68
VENLAFAXINE HCL ER 122 40 48 84
GEMFIBROZIL 122 59 48 114
CIPROFLOXACIN HCL 120 74 50 77
POLYETHYLENE GLYCOL 3350 119 80 51 53
LANTUS SOLOSTAR 113 33 52 102
BUSPIRONE HCL 112 78 53 129
ADVAIR DISKUS 112 48 53 35
LEVETIRACETAM 111 61 55 105
TAMSULOSIN HCL 110 105 56 29
ALLOPURINOL 104 68 57 33
JANUVIA 103 42 58 50
AMOX TR-POTASSIUM CLAVULANATE 100 55 59 164
DOXYCYCLINE HYCLATE 98 53 60 147
LOVAZA 93 24 61 143
PROPRANOLOL HCL 89 28 62 126
NORTRIPTYLINE HCL 88 32 63 244
CYCLOBENZAPRINE HCL 87 0 R 64 87
LANTUS 85 65 65 54
WELCHOL 85 62 65 201
DIVALPROEX SODIUM 85 46 65 99
BUMETANIDE 84 59 68 78
NITROGLYCERIN PATCH 83 75 69 171
IBUPROFEN 82 27 70 75
NIFEDIPINE ER 81 59 71 113
LISINOPRIL-HYDROCHLOROTHIAZIDE 81 45 71 27
ENDOCET 79 25 S2 73 89
RISPERIDONE 77 56 74 62
DIOVAN 76 50 75 31
KLOR-CON M20 75 33 76 48
ROPINIROLE HCL 74 28 77 118
VENLAFAXINE HCL 72 49 78 213
EXELON 71 68 79 150
CLONIDINE HCL 71 62 79 79
QUETIAPINE FUMARATE 71 59 79 82
LACTULOSE 70 53 82 137
OXYCODONE HCL 69 32 S2 83 58
FAMOTIDINE 69 56 83 60
KLOR-CON 10 68 68 85 140
LOPERAMIDE 68 50 85 251
SINGULAIR 67 0 87 95
NITROSTAT 67 36 87 237
SUCRALFATE 67 14 87 225
HYDROMORPHONE HCL 66 66 S2 90 240
CARBIDOPA-LEVODOPA 65 52 91 92
OLANZAPINE 65 57 91 106
GLIPIZIDE 63 38 93 57
TOPIRAMATE 62 0 94 181
NOVOLOG 62 53 94 112
PAROXETINE HCL 62 30 94 59
FLUCONAZOLE 61 31 97 259
METHYLPHENIDATE HCL 61 22 97 305
OXYCODONE HCL-ACETAMINOPHEN 61 33 S2 97 122
SPS 61 50 97 357
SYMBICORT 61 28 97 186
ABILIFY 59 37 102 159
KLOR-CON M10 59 48 102 115
LEVEMIR FLEXPEN 57 28 104 184
PRAVASTATIN SODIUM 57 57 104 15
LANSOPRAZOLE 57 30 104 155
SEROQUEL XR 57 18 104 287
SEROQUEL 56 40 108 161
BACLOFEN 55 0 109 142
QUINAPRIL HCL 55 25 109 74
JANTOVEN 55 40 109 76
VENTOLIN HFA 55 0 109 70
PROAIR HFA 54 0 113 83
AZITHROMYCIN 54 27 113 38
AMPHETAMINE SALT COMBO 53 0 S2 115 280
ACETAMINOPHEN-CODEINE 52 0 S3 116 123
FINASTERIDE 52 52 116 88
CLOTRIMAZOLE-BETAMETHASONE 52 24 116 135
FLUOXETINE HCL 52 23 116 61
MONTELUKAST SODIUM 52 0 116 175
PROCRIT 51 51 121 294
MORPHINE SULFATE ER 50 50 S2 122 104
DIVALPROEX SODIUM ER 50 34 122 198
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 30, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.